The Cell Therapy H1 2025 Landscape Review

Welcome to Beacon’s Cell Therapy H1 2025 Landscape Review series, providing a comprehensive, data-driven look at the global cell therapy market. Across the two-part series, we’ll track the latest drug, trial, and commercial activity shaping the field to help you anticipate where the market is heading next.

Download Part 1 to unpack the most significant shifts and emerging opportunities in the drug pipeline, and explore the future trajectory of cell therapy innovation.

Breaking Boundaries in Cell Therapy:

Growth, Milestones & What’s Next

The cell therapy landscape isn’t just growing – it’s accelerating. With 487 new assets and 489 new trials emerging in H1 2025, the field is on track to explode with innovation and momentum. Perhaps most exciting is the first-ever NDA submission of a CAR T therapy for solid tumors, a watershed moment that could redefine the future of oncology, with ripple effects from China to the United States.

This milestone, along with dozens of other breakthroughs, is unpacked in detail inside the Cell Therapy H1 2025 Landscape Review – Beacon’s exclusive, data-powered report that tracks every shift in drug development, trials, and commercial strategy across the global cell therapy space.

Download your free copy today to get ahead of the curve.

Download Part 1

Cell Therapy H1 2025 LR

Part 1: The Drug Landscape & Future of Cell Therapy

Download Now

Cell Therapy Trial & Commercial Landscape

Part 2: The Trial & Commercial Landscapes

Coming Soon

Report Contents

The Drug Landscape

Explore the full drug landscape analysis, spotlight high-potential assets, and uncover where the next big breakthroughs may come from.

The Trial Landscape

Deep dive into the trial landscape, understand trial trends, sponsors, where trials are taking place, and reasons for trial terminations.

The Commercial Market

A review of cell therapy deals, mergers and acquisitions from H1 2025, as well as cell therapy company type and location.

The Future of Cell Therapy

A glimpse into the future trajectory of the cell therapy space, with a look at armoring technologies, In Vivo CAR, and upcoming milestones.

Previous Cell Therapy Landscape Reviews

Cell Therapy 2024 Landscape Review

Cell Therapy 2024 Landscape Review

An analysis of the Cell Therapy landscape in 2024

Cell Therapy 2024 H1 Landscape Review

An analysis of the Cell Therapy landscape in H1 of 2024

You May also be Interested in…

Learn More About Cell Therapy

What is Beacon Cell Therapy?
  • The Most Comprehensive Way to Search the Cell Therapy Development Landscape: Unique search ontologies based on Cell Therapy drug and trial characteristics
  • Market Leading Approach to Cell Therapy Preclinical & Clinical Data Curation: Manual curation of key Cell Therapy research and development data points by Cell Therapy research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Cell Therapy company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon Cell Therapy

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search